AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitasug M Tablet

Prescription Icon
Prescription Required

Marketer

May and Baker Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitasug M Tablet

Combiflor is a dual-action medication managing elevated blood glucose in patients with type 2 diabetes. This helps mitigate severe diabetic complications like nephropathy and vision impairment, potentially lowering the risk of cardiovascular events. Combiflor may be administered independently or alongside other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent, daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes management; lifestyle plays a pivotal role in disease control. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when used concurrently with insulin or sulfonylureas; prompt recognition and management are essential. This medication isn't suitable for all individuals. Prior to initiating treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical advice before use. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol should be minimized due to its potential to reduce blood glucose levels. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.

Uses of Sitasug M Tablet

Managing Type 2 Diabetes

Major Benefits of Sitasug M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitasug M Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with food.

Common Side effects of Sitasug M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasug M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitasug M Tablet should be administered with a meal.

How Sitasug M Tablet works:

Sitasug M Tablet combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Sitasug M Tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitasug M Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitasug M Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Sitasug M Tablets, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severely compromised kidney function. Regular monitoring of renal function is recommended throughout the treatment period.

LiverLiverUNSAFE

Individuals with liver impairment should likely avoid Sitasug M Tablet due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitasug M Tablet :

Should you forget a Sitasug M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitasug M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitasug M Tablet

Sitasug M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitasug M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitasug M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Sitasug M Tablets are contraindicated in patients with hypersensitivity to any component or excipient. This medication should also be avoided in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasug M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitasug M Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek immediate medical attention.
Sitasug M Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasug M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitasug M Tablets are contraindicated in patients with known hypersensitivity to any ingredient. Avoid use in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasug M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitasug M Tablet) can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitasug M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), necessitating supplemental vitamin B12 at least annually, according to some studies.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasug M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitasug M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasug M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasug M Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin tablets can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitasug M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary or cognitive issues. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasug M Tablet
91
MRP 106
14% off